Showing results (121-130 of 199) with videos related to

Sort By:
Pageof 20
Arthritis Research & Therapy|October 25, 2022
Methotrexate improves endothelial function in early rheumatoid arthritis patients after 3 months of treatmentGiacomo Cafaro, Eleonora Petito, Onelia Bistoni, et al.
Scientific Reports|May 25, 2026
Distinct molecular profile in Sjögren's syndrome is associated with disease activity and clinical manifestationsCarlo Perricone, Giacomo Cafaro, Martina Nicchi, et al.
Rheumatology (Oxford, England)|December 27, 2013
Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patientsChiara Baldini, Pasquale Pepe, Luca Quartuccio, et al.
Frontiers in Immunology|April 12, 2021
Peripheral Nervous System Involvement in Sjögren's Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren's SyndromeGiacomo Cafaro, Carlo Perricone, Francesco Carubbi, et al.
Plos One|January 26, 2019
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glandsFrancesco Carubbi, Alessia Alunno, Paola Cipriani, et al.
Autoimmunity Reviews|July 12, 2015
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolutionLuca Quartuccio, Chiara Baldini, Elena Bartoloni, et al.
Autoimmunity Reviews|March 8, 2012
Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literatureElena Bartoloni, Alessia Alunno, Onelia Bistoni, et al.
Arthritis Research & Therapy|November 30, 2013
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up studyFrancesco Carubbi, Paola Cipriani, Alessandra Marrelli, et al.
Arthritis Research & Therapy|January 24, 2013
Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective studyNicola Bizzaro, Elena Bartoloni, Gabriella Morozzi, et al.
The Journal of Rheumatology|April 3, 2012
Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictorsFlorenzo Iannone, Elisa Gremese, Fabiola Atzeni, et al.
Pageof 20